| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.032 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.054 | 0.9 |